Ideas

December 29, 2017

Published by admin_auro at December 29, 2017

Categories

Natural product-based combinatorial therapy for Lifespan extension: A therapeutic mix encompassing Hydralazine, Catalpol, Cholecalciferol, Maresin, Ursolic acid, DIM, Isoliquiritigenin, & Lutein (HCCMUDIL) activates autophagy, promotes leanness, increases insulin sensitivity, improves motor function, alleviates ageing feature and extends lifespan via up regulation of its target gene ATG5 (Autophagy related 5), 29/December/2017, 11.32 pm

Introduction: What they say A study from the Global Research Laboratory, Seoul National University, Korea shows that “Overexpression of Atg5 in mice activates autophagy and extends lifespan.” This study was […]

December 29, 2017

Published by admin_auro at December 29, 2017

Categories

Natural product-based therapy for Diabetic retinopathy: A pharmaceutical mixture encompassing Nordihydroguaiaretic acid (NDGA), Epicatechin and Matrine (NDGAEM) inhibits Soluble epoxide hydrolase (sEH) expression, decreases toxic 19,20-dihydroxydocosapentaenoic acid levels, inhibits pericyte loss, vascular permeability, and inflammation of the eye and progression of diabetic retinopathy, via down regulation of its target gene, 29/December/2017, 11.22 pm

Introduction: What they say A study from the Institute for Vascular Signalling, Centre for Molecular Medicine, Goethe University, Frankfurt am Main, Germany; and German Centre for […]

December 29, 2017

Published by admin_auro at December 29, 2017

Categories

Natural product-based therapy for body weight control, energy homeostasis and TIIDM: Nateglinide, an anti-hyperglycemic drug, inhibits DNA methyltransferase 3a (Dnmt3a) expression, increases FGF21 expression, augments insulin sensitivity, increases glucose tolerance, and protects from diet-induced obesity and TIIDM, via up regulation of its target gene, 29/December/2017, 11.12 pm

Introduction: What they say A study from Nutritional Sciences and Toxicology Department, University of California, Berkeley, Berkeley, United States shows that “Dnmt3a is an epigenetic mediator […]

December 29, 2017

Published by admin_auro at December 29, 2017

Categories

Natural product-based therapy for Metabolic diseases: A pharmaceutical mixture [PMSFN] encompassing Pyridoxamine(PM) and Sulforaphane (SFN) increases the expression of Caveolin-1, stabilizes insulin receptor, promotes insulin sensitivity, incrases vasorelaxation, and decreases the risk of hyperglycemia and TIIDM via up regulation of its target gene.., 29/December/2017, 11.01 pm

Introduction: What they say A study from the Institute for Molecular Systems Biology, ETH Zurich, Zurich, Switzerland shows that “MicroRNAs 103 and 107 regulate insulin sensitivity.” This study was published, in the June […]